VERZONI, ELENA

VERZONI, ELENA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.01 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 2022 Mennitto A.Zattarin E.Di Lorenzo G.Sepe P.Ottini A.De Braud F. G.Verzoni E. + Article (author) -
Biomarker-driven immunotherapy for precision medicine in prostate cancer 2022 Ottini A.Sepe P.Beninato T.Verzoni E.Giannatempo P.De Braud F.Procopio G. + Article (author) -
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients 2021 Verzoni, Elenade Braud, Filippo + Article (author) -
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 2017 E. VerzoniF. De Braud + Article (author) -
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? 2017 E. VerzoniM. PrisciandaroA. MennittoF. de Braud + Article (author) -
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 2016 E. VerzoniM. NigerF. De BraudR. Valdagni + Article (author) -
Cabozantinib in the treatment of advanced renal cell carcinoma : Design, development, and potential place in the therapy 2016 E. VerzoniA. MennittoF. de Braud + Article (author) -
Immunotherapy advances in uro-genital malignancies 2016 D. RaggiE. VerzoniA. NecchiF. de Braud + Article (author) -
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis 2016 E. VerzoniV. MazzaferroF. De Braud + Article (author) -
Treatment of elderly patients with metastatic renal cell carcinoma 2016 E. VerzoniC. MaggiF. De Braud + Article (author) -
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 2015 D. RaggiP. GiannatempoE. VerzoniF. De BraudA. Necchi + Article (author) -
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis 2015 E. VerzoniF. de Braud + Article (author) -
Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors 2015 I. TestaE. VerzoniR. ValdagniF. De Braud + Article (author) -
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 2015 E. VerzoniA. NecchiP. GiannatempoD. RaggiF. De Braud + Article (author) -
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data 2015 E. VerzoniI. TestaF. De Braud + Article (author) -
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients 2015 I. TestaE. VerzoniG. GalliF. De Braud + Article (author) -
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib 2015 E. VerzoniF. De Braud + Article (author) -
Targeted treatments in advanced renal cell carcinoma : focus on Axitinib 2014 E. VerzoniI. TestaP. BiondaniF. De Braud + Article (author) -
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases 2014 E. VerzoniP. BiondaniI. TestaF. de Braud + Article (author) -
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma : results from a large cohort of patients 2014 P. BiondaniE. VerzoniI. TestaF. De Braud + Article (author) -